Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Daiichi Sankyo Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Daiichi Sankyo Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Daiichi Sankyo Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Daiichi Sankyo Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Daiichi Sankyo Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Daiichi Sankyo Co Ltd, Medical Equipment, Deal Details 11
Venture Financing 11
Ambit Biosciences Raises US$7.07 Million In Venture Financing 11
Partnerships 12
National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 12
Daiichi Sankyo Partners with Nitto Denko 13
Daiichi Sankyo Enters Into Co-Development Agreement With Terumo For Intradermal Vaccine 14
Equity Offering 15
Daiichi Sankyo to Invest in USD196.7 Million in Luitpold Pharma 15
Debt Offering 16
Daiichi Sankyo to Raise USD713.4 Million in Public Offering of 0.81% 5th Series Bonds Due 2036 16
Daiichi Sankyo to Raise USD237.8 Million in Public Offering of 1.2% 6th Series Bonds Due 2046 17
Asset Transactions 18
LYNCH Biologics Acquires Rights and Certain Assets of Luitpold Pharma 18
Acquisition 19
Daiichi Sankyo Acquires Majority Stake in Ambit Biosciences 19
Daiichi Sankyo Co Ltd – Key Competitors 21
Daiichi Sankyo Co Ltd – Key Employees 22
Daiichi Sankyo Co Ltd – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 27
Recent Developments 28
Strategy And Business Planning 28
Aug 01, 2018: Daiichi Sankyo transfers 41 products to Alfresa Pharma 28
Feb 23, 2018: Daiichi Sankyo Announces Organizational Restructuring Effective as of April 1, 2018 29
Jan 09, 2018: Daiichi Sankyo to Convert Kitasato Daiichi Sankyo Vaccine into Wholly Owned Subsidiary 31
Sep 07, 2017: Daiichi Sankyo Announces Organizational Restructuring Effective as of October 1, 2017 32
Feb 24, 2017: Daiichi Sankyo Announces Organizational Restructuring Effective as of April 1, 2017 33
Feb 15, 2017: Daiichi Sankyo Strengthens Authorized Generic Business through Daiichi Sankyo Espha 35
Feb 10, 2017: Daiichi Sankyo Announces Further Reorganization of its Research & Development Structure 37
Corporate Communications 38
May 11, 2018: Daiichi Sankyo Announces Changes to Representative Directors and Members of the Audit and Supervisory Board 38
Feb 21, 2018: Daiichi Sankyo Selected for 2018 Certified Health and Productivity Management Organization (White 500) 39
Feb 02, 2018: Daiichi Sankyo Selected for Silver Class of RobecoSAM Sustainability Award 2018 40
Sep 15, 2017: Daiichi Sankyo Listed on the Dow Jones Sustainability Indices World Index 41
Feb 24, 2017: Daiichi Sankyo Appoints New Group Corporate Officers 42
Jan 31, 2017: Daiichi Sankyo Announces New Chairman and President 43
Legal and Regulatory 44
Jun 06, 2018: Daiichi Sankyo’s U.S. Products Liability Litigation Settlement Program Moves Forward; More than 97 Percent of Eligible Litigants and Claimants Opt In 44
Government and Public Interest 45
Jul 11, 2017: Daiichi Sankyo Selected for Ninth Consecutive Year as Constituent of FTSE4Good Global Index by FTSE Russell 45
Jul 03, 2017: 15th Takamine Memorial Daiichi Sankyo Prize Winner Announced 46
Other Significant Developments 47
Feb 28, 2018: Daiichi Sankyo Aligns U.S. Commercial Operations to Current Portfolio and Upcoming Cancer Pipeline 47
Jun 20, 2017: Daiichi Sankyo Selects Deloitte’s ConvergeHEALTH Safety to Transform and Upgrade Global Drug Safety Platform 48
Apr 27, 2017: Daiichi Sankyo Announces 15 Billion Yen Manufacturing Investment to Support Acceleration of Antibody Drug Conjugate Portfolio 49
Jan 10, 2017: Daiichi Sankyo Announces Reorganization of Research & Development System 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51
Daiichi Sankyo Co Ltd, Medical Equipment, Key Facts, 2018 2
Daiichi Sankyo Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Daiichi Sankyo Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Daiichi Sankyo Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Daiichi Sankyo Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Daiichi Sankyo Co Ltd, Deals By Market, 2012 to YTD 2018 9
Daiichi Sankyo Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Ambit Biosciences Raises US$7.07 Million In Venture Financing 11
National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 12
Daiichi Sankyo Partners with Nitto Denko 13
Daiichi Sankyo Enters Into Co-Development Agreement With Terumo For Intradermal Vaccine 14
Daiichi Sankyo to Invest in USD196.7 Million in Luitpold Pharma 15
Daiichi Sankyo to Raise USD713.4 Million in Public Offering of 0.81% 5th Series Bonds Due 2036 16
Daiichi Sankyo to Raise USD237.8 Million in Public Offering of 1.2% 6th Series Bonds Due 2046 17
LYNCH Biologics Acquires Rights and Certain Assets of Luitpold Pharma 18
Daiichi Sankyo Acquires Majority Stake in Ambit Biosciences 19
Daiichi Sankyo Co Ltd, Key Competitors 21
Daiichi Sankyo Co Ltd, Key Employees 22
Daiichi Sankyo Co Ltd, Subsidiaries 24
Daiichi Sankyo Co Ltd, Joint Venture 27
List of Figures
Daiichi Sankyo Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Daiichi Sankyo Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Daiichi Sankyo Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Daiichi Sankyo Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Daiichi Sankyo Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Daiichi Sankyo Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Daiichi Sankyo Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Daiichi Sankyo Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9